Ā 

License to Market Kremezin (drug for chronic renal failure) in Japan - PharmaLive.com (press release) PDF Print
PharmaLive.com (press release)... 2009, under which KUREHA shall grant Mitsubishi Tanabe a license to market KremezinĀ® in Japan, a drug for chronic renal failure developed by KUREHA.

... read more

 
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.